Increases in Serum Cholesterol with Baricitinib Treatment are Associated with Favorable Changes in Apolipoprotein Content and with Improvement in DAS28-CRP in Patients with Rheumatoid Arthritis

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions